Cost analysis study of commonly used oral hypoglycaemic agents available in India- a pharmacoeconomic study

Journal Title: Indian Journal of Pharmacy and Pharmacology - Year 2017, Vol 4, Issue 1

Abstract

Objectives: To assess the difference in cost percentage variation of various brands of oral hypoglycaemic drugs available in single and in combination in Indian market. Materials and Methods: An observational study was carried out using ‘Current index in medical specialities’, ‘reference Rx’, & ‘Indian drug referral’ (July-Oct 2014), where in the difference in the maximum and minimum price of a particular drug, manufactured by different pharmaceutical companies, in the same strength, number and dosage form was compared and the percentage variation in price was calculated. Data is analysed using descriptive statistical analysis. Results: The minimum and maximum percentage price variation for different classes of drugs respectively is as follows: In Single drug therapy, among sulfonylurea group of drugs, Glimepiride (2mg) & Glicazide (80mg) shows maximum and minimum price variation of 730.93% & 165.55% respectively. Among Biguanides & Thiazolidinediones groups, Metformin (500 mg) & Pioglitazone (15mg) show maximum price variation of 402.92% & 483.33% respectively. In α-glucosidases inhibitor group of drugs, Voglibose (0.2mg) shows maximum price variation of 451.28 %. Among newer DPP4 (Dipeptide peptidase 4) inhibitors Vildagliptin (50mg) shows maximum cost variation of 100%. In combination therapies Glimipiride & Pioglitazone combination shows the maximum variation up to 307.7%. Conclusion: The percentage cost variation of different brands of the same drug manufactured in India is very wide and the reason behind marketing a drug should be directed towards maximizing the benefit of therapy and minimizing negative personal and economic consequences.

Authors and Affiliations

Dharani Devangi R, Rajesh B, Shashirekha CH

Keywords

Related Articles

An observational study to analyse the dose appropriateness of drugs prescribed in intensive care units of pediatric department

Introduction Pediatric age group comprises about 40 of total population of India Many medications are available to children and the safety of paediatric medications is an important public health issue The challenge all t...

Unlicensed and off-label utilization of drugs in pediatric department at tertiary care teaching hospital: A prospective study

Background: The treatment of pediatric patients with drugs in hospitals is being impeded by a shortage in the availability of licensed drugs in an appropriate formulation. Aim of this study is to assess the extent of use...

Anti-Cancer potentials of the plant Aquilaria malaccensis leaves

In the present study the ethanolic extract of Aquilaria malaccensis Agar wood leaves before inoculation BF and after inoculation AF was evaluated for its anticancer potentials The leaf extracts BF and AF was subjected to...

Migraine: Diagnosis and Prophylactic Management

Migraine is the most common type of vascular headache characterized by recurrent attacks of headache, which typically lasts for 4 to 72 hours. Recurrent attacks of migraine affect the patients’ quality of life, social ac...

Nootropic Effect of Berberine in Colchicines Induced Experimental Alzheimer’s Disease Model: Effect on Cholinergic Neurotransmission

Background & Objectives: Colchicine administration by ICV is well known model which shows sporadic dementia of the Alzheimer type in humans, causing cognitive impairment and oxidative damage. Berberine (BBR) is a natural...

Download PDF file
  • EP ID EP295557
  • DOI 10.18231/2393-9087.2017.0006
  • Views 92
  • Downloads 0

How To Cite

Dharani Devangi R, Rajesh B, Shashirekha CH (2017). Cost analysis study of commonly used oral hypoglycaemic agents available in India- a pharmacoeconomic study. Indian Journal of Pharmacy and Pharmacology, 4(1), 22-26. https://europub.co.uk/articles/-A-295557